(-)-Calanolide B
(-)-Calanolide B is a non-nucleoside reverse transcriptase (NNRT) inhibitor with an IC50 of 0.5 mM against HIV-1 RT. (-)-Calanolide B inhibits the replication of HIV-1 IIIb/LAV. (-)-Calanolide B is applicable to research related to HIV-1 infection.
For research use only. We do not sell to patients.
- CAS No.: 909-14-8
- Formula: C22H26O5
- Molecular Weight:370.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
HIV-1 RT 0.5 mM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CCRF-CEM | IC50 |
18.7 μM
Compound: (-)-1
|
Anti-HIV activity against HIV-I RFII strain in CEM cell line
Anti-HIV activity against HIV-I RFII strain in CEM cell line
|
[PMID: 8632437] |
| CEM-SS | EC50 |
0.2 μM
Compound: 2
|
Using the XTT assay for cell viability, effective concentration to protect human lymphoblastoid CEM-SS cells from the cytopathic effects of HIV-1 (RF strain) was determined
Using the XTT assay for cell viability, effective concentration to protect human lymphoblastoid CEM-SS cells from the cytopathic effects of HIV-1 (RF strain) was determined
|
[PMID: 8893846] |
| CEM-SS | IC50 |
5.9 μM
Compound: 2
|
Using the XTT assay for cell viability, inhibitory concentration to protect human lymphoblastoid CEM-SS cells from the cytopathic effects of HIV-1 (RF strain) was determined
Using the XTT assay for cell viability, inhibitory concentration to protect human lymphoblastoid CEM-SS cells from the cytopathic effects of HIV-1 (RF strain) was determined
|
[PMID: 8893846] |
| CEM-SS | EC50 |
0.2 μM
Compound: (-)-Calanolide B
|
Antiviral activity against HIV1 RF in human CEM-SS cells assessed as inhibition of virus-induced cytopathic effect
Antiviral activity against HIV1 RF in human CEM-SS cells assessed as inhibition of virus-induced cytopathic effect
|
[PMID: 11430019] |
| H9 | EC50 |
0.22 μM
Compound: 13
|
Antiviral activity against HIV1 infected in human H9 cells assessed as effect on virus-induced cytopathic effect by tetrazolium/formazan assay
Antiviral activity against HIV1 infected in human H9 cells assessed as effect on virus-induced cytopathic effect by tetrazolium/formazan assay
|
[PMID: 8792623] |
| H9 | IC50 |
9.8 μM
Compound: 13
|
Cytotoxicity against human H9 cells
Cytotoxicity against human H9 cells
|
[PMID: 8792623] |
| MT2 | IC50 |
5.89 μM
Compound: (-)-1
|
Anti-HIV activity against HIV-I A17 strain in MT2 cell line
Anti-HIV activity against HIV-I A17 strain in MT2 cell line
|
[PMID: 8632437] |
| MT2 | IC50 |
6.16 μM
Compound: (-)-1
|
Anti-HIV activity against HIV-I G910-6 strain in MT2 cell line
Anti-HIV activity against HIV-I G910-6 strain in MT2 cell line
|
[PMID: 8632437] |
| MT2 | IC50 |
6.21 μM
Compound: (-)-1
|
Anti-HIV activity against HIV-I H112-2 strain in MT2 cell line
Anti-HIV activity against HIV-I H112-2 strain in MT2 cell line
|
[PMID: 8632437] |
| MT2 | IC50 |
7.31 μM
Compound: (-)-1
|
Anti-HIV activity against HIV-I IIIB strain in MT2 cell line
Anti-HIV activity against HIV-I IIIB strain in MT2 cell line
|
[PMID: 8632437] |
In Vitro
Chemical Information
-
CAS No. 909-14-8
-
Molecular Weight 370.44
-
Formula C22H26O5
-
SMILES
CCCC(C1=C(O2)C3=C(O[C@H]([C@@H]([C@@H]3O)C)C)C4=C1OC(C)(C=C4)C)=CC2=O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)